CPRX Catalyst Pharmaceuticals, Inc. Stock Quote

CPRX [NASD]

Index	-	P/E	7.40	EPS (ttm)	0.70	Insider Own	7.10%	Shs Outstand	103.41M	Perf Week	7.01%
Market Cap	531.25M	Forward P/E	9.51	EPS next Y	0.55	Insider Trans	-6.58%	Shs Float	95.62M	Perf Month	-2.99%
Income	74.60M	PEG	-	EPS next Q	0.10	Inst Own	66.30%	Short Float	5.46%	Perf Quarter	-12.63%
Sales	126.90M	P/S	4.19	EPS this Y	134.70%	Inst Trans	-2.87%	Short Ratio	6.63	Perf Half Y	22.99%
Book/sh	1.83	P/B	2.84	EPS next Y	39.29%	ROA	38.60%	Target Price	8.30	Perf Year	64.24%
Cash/sh	1.52	P/C	3.42	EPS next 5Y	-	ROE	43.00%	52W Range	2.88 - 6.24	Perf YTD	55.39%
Dividend	-	P/FCF	-	EPS past 5Y	37.00%	ROI	43.90%	52W High	-16.76%	Beta	1.37
Dividend %	-	Quick Ratio	10.50	Sales past 5Y	-	Gross Margin	85.80%	52W Low	80.52%	ATR	0.18
Employees	74	Current Ratio	10.90	Sales Q/Q	23.00%	Oper. Margin	36.20%	RSI (14)	49.38	Volatility	3.21% 3.56%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	23.40%	Profit Margin	58.80%	Rel Volume	0.72	Prev Close	5.08
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 09 AMC	Payout	0.00%	Avg Volume	787.14K	Price	5.19
Recom	2.00	SMA20	0.98%	SMA50	-5.30%	SMA200	8.84%	Volume	630,296	Change	2.17%

Sep-21-18

Initiated

Cantor Fitzgerald

Overweight

Sep-07-18

Resumed

Piper Jaffray

Overweight

Oct-05-16

Upgrade

Piper Jaffray

Neutral → Overweight

Apr-26-16

Downgrade

Piper Jaffray

Overweight → Neutral

$6 → $1

Sep-30-14

Reiterated

ROTH Capital

Buy

$5 → $6

Sep-16-14

Reiterated

ROTH Capital

Buy

$3.50 → $5

Sep-15-14

Reiterated

H.C. Wainwright

Buy

$5 → $13

Oct-21-13

Reiterated

Aegis Capital

Buy

$4 → $5.50

Sep-24-13

Initiated

Maxim Group

Buy

Sep-06-13

Reiterated

Aegis Capital

Buy

$3.50 → $4

Apr-18-13

Initiated

Aegis Capital

Buy

$2.50

Aug-27-12

Upgrade

Rodman & Renshaw

Mkt Perform → Mkt Outperform

$3.70

Oct-01-09

Upgrade

Merriman

Sell → Neutral

May-29-09

Downgrade

Merriman Curhan Ford

Buy → Sell

May-29-09

Downgrade

Hapoalim

Neutral → Underperform

Dec-15-08

Initiated

Merriman Curhan Ford

Buy

Nov-28-07

Initiated

Rodman & Renshaw

Mkt Outperform

Jan-31-07

Initiated

Stifel Nicolaus

Buy

Jan-05-07

Initiated

First Albany

Buy

$10

Sep-17-21 08:03AM	Catalyst Pharmaceuticals to Participate at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire
Sep-10-21 08:03AM	Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences GlobeNewswire
Sep-08-21 11:30AM	Why Is Catalyst (CPRX) Down 12.6% Since Last Earnings Report? Zacks
Aug-16-21 08:03AM	Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations GlobeNewswire -5.46%
Aug-09-21 06:55PM	Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Top Estimates Zacks
04:39PM	Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
Aug-02-21 03:01PM	Catalyst Pharmaceutical (CPRX) Reports Next Week: What Awaits? Zacks
Jul-26-21 08:03AM	Catalyst Pharmaceuticals to Hold Second Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 10th, 2021 GlobeNewswire
Jul-23-21 04:03AM	What Type Of Shareholders Own The Most Number of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares? Simply Wall St.
Jul-19-21 08:03AM	Catalyst Pharmaceuticals Announces Issuance of U.S. Patent 11,060,128 a Method of Use Patent with Claims Covering Firdapse® GlobeNewswire
Jul-06-21 08:03AM	Catalyst Pharmaceuticals Expands Leadership Team with Appointment of Preethi Sundaram, Ph.D. as Chief Product Development Officer GlobeNewswire
Jun-29-21 08:03AM	Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors GlobeNewswire
Jun-28-21 04:30PM	Catalyst Pharmaceuticals Comments on Recent Decision by Health Canada to Re-issue an NOC for Ruzurgi® GlobeNewswire
08:03AM	Catalyst Pharmaceuticals Announces Exclusive License and Supply Agreement with DyDo Pharma for the Development and Commercialization of Firdapse® in Japan GlobeNewswire
Jun-16-21 02:38AM	Did You Miss Catalyst Pharmaceuticals' (NASDAQ:CPRX) Whopping 567% Share Price Gain? Simply Wall St.
Jun-09-21 11:30AM	Catalyst (CPRX) Up 18.6% Since Last Earnings Report: Can It Continue? Zacks
Jun-03-21 03:09PM	Catalyst Pharmaceuticals, Inc.'s and KYE Pharmaceuticals' Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi® CNW Group
01:20PM	Catalyst Pharmaceuticals, Inc.s and KYE Pharmaceuticals Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi® GlobeNewswire
May-19-21 08:03AM	Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences GlobeNewswire
May-11-21 06:30AM	Catalyst Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
03:06AM	Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following Fundamentals? Simply Wall St.
May-10-21 07:05PM	Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings Estimates Zacks
05:29PM	Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
May-08-21 06:12AM	This Under-the-Radar Pharma Company's Recent Success Is Just the Beginning Motley Fool
May-03-21 03:01PM	Earnings Preview: Catalyst Pharmaceutical (CPRX) Q1 Earnings Expected to Decline Zacks +6.33%
08:05AM	Catalyst Pharmaceuticals to Hold First Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 11th, 2021 GlobeNewswire
Apr-14-21 11:30AM	Why Is Catalyst (CPRX) Up 8.9% Since Last Earnings Report? Zacks
Apr-05-21 01:03AM	Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Catapults 28% Though Its Price And Business Still Lag The Market Simply Wall St.
Mar-22-21 08:03AM	Catalyst Pharmaceuticals Announces $40 Million Share Repurchase Program GlobeNewswire +7.32%
Mar-21-21 04:42AM	With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Is Interesting Simply Wall St.
Mar-18-21 06:02PM	Top Biotech Stocks for Q2 2021 Investopedia
Mar-16-21 10:38AM	Catalyst Pharma 4Q Revenue, Earnings Outperform Estimates SmarterAnalyst +5.33%
06:30AM	Catalyst Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-15-21 06:45PM	Catalyst Pharmaceutical (CPRX) Beats Q4 Earnings and Revenue Estimates Zacks
05:26PM	Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update GlobeNewswire
Mar-08-21 12:30PM	Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Mar-04-21 11:00AM	Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 16th, 2021 GlobeNewswire
Feb-22-21 08:03AM	Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2021 GlobeNewswire
Feb-13-21 02:41AM	What Is The Ownership Structure Like For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)? Simply Wall St.
Jan-28-21 10:44AM	Looking Into Catalyst Pharmaceuticals's Return On Capital Employed Benzinga
Jan-06-21 08:07AM	Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update GlobeNewswire
Dec-30-20 01:42AM	If You Had Bought Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Five Years Ago, You Could Pocket A 43% Gain Today Simply Wall St.
Dec-16-20 12:32PM	Is CPRX A Good Stock To Buy Now? Insider Monkey
Dec-09-20 11:30AM	Why Is Catalyst (CPRX) Up 4.4% Since Last Earnings Report? Zacks
Nov-15-20 07:50AM	What You Need To Know About The Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Analyst Downgrade Today Simply Wall St.
Nov-11-20 05:44AM	Results: Catalyst Pharmaceuticals, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts Simply Wall St.
Nov-09-20 06:35PM	Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings Estimates Zacks +5.08%
05:20PM	Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Nov-02-20 08:03AM	Catalyst Pharmaceuticals to Hold Third Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, November 10th, 2020 GlobeNewswire
Oct-28-20 10:33AM	Looking Into Catalyst Pharmaceuticals's Return On Capital Employed Benzinga
Oct-19-20 06:03AM	Catalyst Pharmaceuticals Announces Filing of Patent Infringement Actions Against Jacobus Pharmaceuticals and PantherRx GlobeNewswire
Oct-08-20 07:32AM	Will Weakness in Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Prove Temporary Given Strong Fundamentals? Simply Wall St.
Oct-06-20 05:46PM	Hedge Funds Are Crazy About Catalyst Pharmaceuticals, Inc. (CPRX) Insider Monkey
11:15AM	Catalyst Pharmaceuticals Announces Issuance of U.S. Patent for Firdapse® GlobeNewswire
10:01AM	Return On Capital Employed Overview: Catalyst Pharmaceuticals Benzinga
Sep-29-20 04:40PM	Catalyst Pharmaceuticals Announces Ruling on Lawsuit against the FDA and Intent to Appeal GlobeNewswire
Sep-09-20 11:30AM	Why Is Catalyst (CPRX) Down 7.5% Since Last Earnings Report? Zacks
Sep-08-20 11:00AM	Why Catalyst Pharmaceuticals Stock Crashed in August Motley Fool
Aug-26-20 09:40AM	KYE Pharmaceuticals and Catalyst Pharmaceuticals Challenge Health Canadas Decision to Overlook Firdapse® Data Exclusivity GlobeNewswire
Aug-24-20 09:05AM	A Look At Catalyst Pharmaceuticals' (NASDAQ:CPRX) CEO Remuneration Simply Wall St.
Aug-18-20 08:03AM	Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce Agreement to Make Firdapse® (amifampridine phosphate) Available to LEMS Patients in Canada GlobeNewswire
Aug-16-20 09:12AM	5 Midcap Magic Formula Stocks For Total Return Insider Monkey
Aug-14-20 10:30AM	ROCE Insights For Catalyst Pharmaceuticals Benzinga
Aug-11-20 09:27AM	Why Catalyst Pharmaceuticals Stock Is Crashing Today Motley Fool -21.69%
06:00AM	Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. Patent Application for "Methods of Administering 3,4-Diaminopyridine" GlobeNewswire
Aug-10-20 05:55PM	Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Surpass Estimates Zacks +5.31%
04:15PM	Catalyst Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Aug-07-20 11:11AM	Earnings Preview: Catalyst Pharmaceuticals Benzinga
Aug-06-20 08:03AM	Catalyst Pharmaceuticals Firdapse® (amifampridine phosphate) Receives Marketing Approval in Canada for Patients with LEMS GlobeNewswire
Aug-03-20 04:15PM	Catalyst Pharmaceuticals Announces Change to a Virtual Meeting Format for the 2020 Annual Meeting of Stockholders GlobeNewswire
08:03AM	Catalyst Pharmaceuticals to Hold Second Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 11th, 2020 GlobeNewswire
Jul-31-20 11:10AM	Catalyst Pharmaceuticals Comments on Magistrate Judge's Report and Recommendation in its Lawsuit against the FDA GlobeNewswire -8.51%
Jul-29-20 12:33PM	Earnings Preview: Catalyst Pharmaceutical (CPRX) Q2 Earnings Expected to Decline Zacks
Jul-28-20 11:11AM	Did Hedge Funds Make The Right Call On Catalyst Pharmaceuticals, Inc. (CPRX) ? Insider Monkey
Jul-16-20 12:44PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Catalyst Pharmaceuticals, Inc. - CPRX Newsfile
Jul-14-20 12:55PM	INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Catalyst Pharmaceuticals, Inc. for Potential Breach of Fiduciary Duty Claims ACCESSWIRE
Jul-10-20 01:48PM	3 US Small-Cap Stocks to Consider for Market Recovery GuruFocus.com
Jul-09-20 03:03PM	Do Institutions Own Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares? Simply Wall St.
Jun-23-20 08:03AM	Catalyst Pharmaceuticals Appoints Jeffrey Del Carmen as Chief Commercial Officer GlobeNewswire
Jun-22-20 10:49AM	Hedge Funds Have Never Been This Bullish On Catalyst Pharmaceuticals, Inc. (CPRX) Insider Monkey
Jun-18-20 09:12PM	Edited Transcript of CPRX.OQ earnings conference call or presentation 12-May-20 12:30pm GMT Thomson Reuters StreetEvents
Jun-10-20 11:30AM	Catalyst (CPRX) Down 0.4% Since Last Earnings Report: Can It Rebound? Zacks
Jun-01-20 08:03AM	Catalyst Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-17-20 08:31AM	What Does The Future Hold For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)? These Analysts Have Been Cutting Their Estimates Simply Wall St.
May-14-20 08:18AM	Catalyst Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions Simply Wall St.
May-11-20 07:25PM	Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings Estimates Zacks
04:17PM	Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
May-04-20 08:03AM	Catalyst Pharmaceuticals to Hold First Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 12th, 2020 GlobeNewswire +7.83%
Apr-29-20 10:02AM	Healthcare Pro Steven Boyd Is Gobbling Up These 3 Stocks TipRanks
05:33AM	Is Catalyst Pharmaceuticals a Buy? Motley Fool
Apr-15-20 11:30AM	Catalyst (CPRX) Up 52.1% Since Last Earnings Report: Can It Continue? Zacks
Apr-08-20 06:00AM	Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business Activities GlobeNewswire +11.83%
Apr-06-20 09:04AM	Edited Transcript of CPRX earnings conference call or presentation 17-Mar-20 12:30pm GMT Thomson Reuters StreetEvents +11.05%
Mar-17-20 06:30AM	Catalyst Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE +10.73%
Mar-16-20 05:26PM	Catalyst Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update GlobeNewswire -23.46%
Mar-10-20 08:03AM	Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 17th, 2020 GlobeNewswire +9.48%
Mar-09-20 12:30PM	Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: What to Know Ahead of Q4 Release Zacks -11.90%
Feb-27-20 08:03AM	Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020 GlobeNewswire -10.30%
Feb-26-20 08:03AM	Catalyst Pharmaceuticals to Present at the Cowen 40th Annual Health Care Conference GlobeNewswire
Feb-24-20 09:42AM	Based On Its ROE, Is Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) A High Quality Stock? Simply Wall St. -5.76%

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS) and myasthenia gravis; and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of anti-MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COELHO PHILIP H	Director	Aug 26	Option Exercise	3.12	16,666	51,998	247,768	Aug 26 04:45 PM
COELHO PHILIP H	Director	Aug 26	Sale	5.45	9,548	52,042	238,220	Aug 26 04:45 PM
COELHO PHILIP H	Director	Aug 25	Option Exercise	3.12	16,667	52,001	240,600	Aug 26 04:45 PM
Miller Steve	Chief Operating Officer	Aug 25	Option Exercise	3.12	120,000	374,400	821,724	Aug 26 04:47 PM
Miller Steve	Chief Operating Officer	Aug 25	Sale	5.56	80,000	444,640	741,724	Aug 26 04:47 PM
COELHO PHILIP H	Director	Aug 25	Sale	5.56	9,498	52,809	231,102	Aug 26 04:45 PM
COELHO PHILIP H	Director	Aug 24	Option Exercise	3.12	16,667	52,001	233,427	Aug 26 04:45 PM
COELHO PHILIP H	Director	Aug 24	Sale	5.58	9,494	52,929	223,933	Aug 26 04:45 PM
MCENANY PATRICK J	President and CEO	Aug 23	Option Exercise	3.12	120,000	374,400	4,994,143	Aug 24 05:01 PM
MCENANY PATRICK J	President and CEO	Aug 23	Sale	5.62	82,617	464,721	4,911,526	Aug 24 05:01 PM
MCENANY PATRICK J	President and CEO	Aug 20	Option Exercise	3.12	80,000	249,600	4,928,304	Aug 24 05:01 PM
MCENANY PATRICK J	President and CEO	Aug 20	Sale	5.52	54,161	298,860	4,874,143	Aug 24 05:01 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 18	Option Exercise	3.12	70,000	218,400	477,441	Aug 19 05:07 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 18	Sale	5.68	13,000	73,879	464,441	Aug 19 05:07 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 17	Option Exercise	3.12	100,000	312,000	507,441	Aug 19 05:07 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 17	Sale	5.67	100,000	566,900	407,441	Aug 19 05:07 PM
O'Keeffe Charles B	Director	Aug 16	Option Exercise	3.12	50,000	156,000	611,709	Aug 17 04:55 PM
Tierney David S	Director	Aug 13	Option Exercise	3.12	50,000	156,000	356,874	Aug 17 04:48 PM
Miller Steve	Chief Operating Officer	Aug 13	Option Exercise	3.12	65,000	202,800	742,687	Aug 17 04:51 PM
MCENANY PATRICK J	President and CEO	Aug 13	Option Exercise	3.12	100,000	312,000	4,911,019	Aug 17 04:53 PM
MCENANY PATRICK J	President and CEO	Aug 13	Sale	6.12	62,715	384,065	4,848,304	Aug 17 04:53 PM
Miller Steve	Chief Operating Officer	Aug 13	Sale	6.09	40,963	249,416	701,724	Aug 17 04:51 PM
Tierney David S	Director	Aug 13	Sale	6.08	50,000	303,895	306,874	Aug 17 04:48 PM
INGENITO GARY	Chief Medical Officer	Dec 22	Sale	3.45	3,668	12,644	10,998	Dec 28 04:47 PM
O'Keeffe Charles B	Director	Sep 30	Buy	2.99	7,000	20,930	560,376	Sep 30 02:23 PM
MCENANY PATRICK J	President and CEO	Sep 30	Buy	2.97	15,000	44,550	4,787,693	Sep 30 10:55 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience